4.590CADMkt Cap: 143.55M CADP/E: —Last update: 2026-05-21
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and inter…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 168.3
54.96BEURP/E 21.7
52.53BTRYP/E 27.3
33.63BPLNP/E 21.9
13.36BSEKP/E 40.3
13.24BEURP/E 30.2
12.58BTRY—
3.96BUSDP/E 33.6
loading…
Indicators:|
Key Statistics
Company
Market Cap143.55M CAD
Enterprise Value183.84M CAD
Revenue (TTM)55.74M CAD
Gross Profit45.42M CAD
Net Income (TTM)-12.43M CAD
Revenue/Share1.752 CAD
Last Price4.590 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees85
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-111.28
PEG—
EV/EBITDA10.60
EV/Revenue3.30
P/S2.58
P/B1.87
EPS (TTM)-0.44
EPS (Forward)-0.04
52W Range
4.490100% of range4.590
52W High4.590 CAD
52W Low4.490 CAD
Profitability
Gross Margin81.83%
Oper. Margin-17.22%
EBITDA Margin31.12%
Profit Margin-22.40%
ROE-20.16%
ROA-9.04%
Growth
Revenue Growth1.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF17.13M CAD
CapEx (TTM)1.70M CAD
FCF Margin35.85%
FCF Yield13.92%
Net Debt33.23M CAD
Net Debt/EBITDA1.92
Balance Sheet
Debt/Equity0.81
Current Ratio1.00
Quick Ratio0.71
Book Value/Sh2.454 CAD
Cash/Share0.3760 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield1.73%
Payout Ratio0.00%
Ex-Div DateApr 27, 2023
Pay DateJun 15, 2023
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)7.148 CAD
Target Range4.509 CAD – 12.05 CAD
# Analysts4
Ownership
Shares Out.31.27M
Float20.58M
Insiders0.53%
Institutions43.42%
Short Interest
Short Ratio1.1d
Short % Out.0.02%
Shares Short14.53K
Short (prev mo.)14.70K
Technical
SMA 504.525 (+1.4%)
SMA 2004.917 (-6.7%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)2.10K
Avg Vol (10d)4.61K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—